SOCS3 Drives Proteasomal Degradation of TBK1 and Negatively Regulates Antiviral Innate Immunity

REFERENCES

• Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann K-K, Schlee M, Endres S, Hartmann G. 2006. 5′-triphosphate RNA is the ligand for RIG-I. Science 314:994–997. http://dx.doi.org/10.1126/science.1132505.
   PubMed Web of Science ®Google Scholar
• Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Sousa CRE. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997–1001. http://dx.doi.org/10.1126/science.1132998.
   PubMed Web of Science ®Google Scholar
• Seth RB, Sun LJ, Ea CK, Chen ZJJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 122:669–682. http://dx.doi.org/10.1016/j.cell.2005.08.012.
   PubMed Web of Science ®Google Scholar
• Xu LG, Wang YY, Han KJ, Li LY, Zhai ZH, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727–740. http://dx.doi.org/10.1016/j.molcel.2005.08.014.
   PubMed Web of Science ®Google Scholar
• McWhirter SM, ten Oever BR, Maniatis T. 2005. Connecting mitochondria and innate immunity. Cell 122:645–647. http://dx.doi.org/10.1016/j.cell.2005.08.026.
   PubMed Web of Science ®Google Scholar
• Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227–264. http://dx.doi.org/10.1146/annurev.biochem.67.1.227.
   PubMed Web of Science ®Google Scholar
• Krebs DL, Hilton DJ. 2001. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378–387. http://dx.doi.org/10.1634/stemcells.19-5-378.
   PubMed Web of Science ®Google Scholar
• Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G, Kile BJ, Kent SBH, Alexander WS, Metcalf D, Hilton DJ, Nicola NA, Baca M. 1999. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A 96:2071–2076. http://dx.doi.org/10.1073/pnas.96.5.2071.
   PubMed Web of Science ®Google Scholar
• Piessevaux J, Lavens D, Peelman F, Tavernier J. 2008. The many faces of the SOCS box. Cytokine Growth Factor Rev 19:371–381. http://dx.doi.org/10.1016/j.cytogfr.2008.08.006.
   PubMed Web of Science ®Google Scholar
• Babon JJ, McManus EJ, Yao SG, DeSouza DP, Mielke LA, Sprigg NS, Willson TA, Hilton DJ, Nicola NA, Baca M, Nicholson SE, Norton RS. 2006. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. Mol Cell 22:205–216. http://dx.doi.org/10.1016/j.molcel.2006.03.024.
   PubMed Web of Science ®Google Scholar
• Sasaki A, Yasukawa H, Suzuki A, Kamizono S, Syoda T, Kinjyo I, Sasaki M, Johnston JA, Yoshimura A. 1999. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4:339–351. http://dx.doi.org/10.1046/j.1365-2443.1999.00263.x.
   PubMed Web of Science ®Google Scholar
• Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka S, Imaizumi T, Matsuda T, Ihle JN, Yoshimura A. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 18:1309–1320. http://dx.doi.org/10.1093/emboj/18.5.1309.
   PubMed Web of Science ®Google Scholar
• Pothlichet J, Chignard M, Si-Tahar M. 2008. Innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNARI-dependent pathway. J Immunol 180:2034–2038. http://dx.doi.org/10.4049/jimmunol.180.4.2034.
   PubMed Web of Science ®Google Scholar
• Pauli E-K, Schmolke M, Wolff T, Viemann D, Roth J, Bode JG, Ludwig S. 2008. Influenza A virus inhibits type I IFN signaling via NF-κB-dependent induction of SOCS-3 expression. PLoS Pathog 4:e1000196. http://dx.doi.org/10.1371/journal.ppat.1000196.
   PubMed Web of Science ®Google Scholar
• Yokota S, Yokosawa N, Okabayashi T, Suzutani T, Miura S, Jimbow K, Fujii N. 2004. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J Virol 78:6282–6286. http://dx.doi.org/10.1128/JVI.78.12.6282-6286.2004.
   PubMed Web of Science ®Google Scholar
• Akhtar LN, Qin H, Muldowney MT, Yanagisawa LL, Kutsch O, Clements JE, Benveniste EN. 2010. Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages. J Immunol 185:2393–2404. http://dx.doi.org/10.4049/jimmunol.0903563.
   PubMedGoogle Scholar
• Frobose H, Ronn SG, Heding PE, Mendoza H, Cohen P, Mandrup-Poulsen T, Billestrup N. 2006. Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol Endocrinol 20:1587–1596. http://dx.doi.org/10.1210/me.2005-0301.
   PubMed Web of Science ®Google Scholar
• Zhao W. 2013. Negative regulation of TBK1-mediated antiviral immunity. FEBS Lett 587:542–548. http://dx.doi.org/10.1016/j.febslet.2013.01.052.
   PubMed Web of Science ®Google Scholar
• Wang C, Chen T, Zhang J, Yang M, Li N, Xu X, Cao X. 2009. The E3 ubiquitin ligase Nrdp1 ‘preferentially' promotes TLR-mediated production of type I interferon. Nat Immunol 10:744–752. http://dx.doi.org/10.1038/ni.1742.
   PubMed Web of Science ®Google Scholar
• Li S, Wang L, Berman M, Kong Y-Y, Dorf ME. 2011. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35:426–440. http://dx.doi.org/10.1016/j.immuni.2011.06.014.
   PubMed Web of Science ®Google Scholar
• Friedman CS, O'Donnell MA, Legarda-Addison D, Ng A, Cardenas WB, Yount JS, Moran TM, Basler CF, Komuro A, Horvath CM, Xavier R, Ting AT. 2008. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 9:930–936. http://dx.doi.org/10.1038/embor.2008.136.
   PubMed Web of Science ®Google Scholar
• Gao L, Coope H, Grant S, Ma A, Ley SC, Harhaj EW. 2011. ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling. J Biol Chem 286:36592–36602. http://dx.doi.org/10.1074/jbc.M111.283762.
   PubMedGoogle Scholar
• Cui J, Li Y, Zhu L, Liu D, Zhou S, Wang HY, Wang R-F. 2012. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol 13:387–395. http://dx.doi.org/10.1038/ni.2239.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang L, Zhao X, Zhao K, Meng H, Zhao W, Gao C. 2012. TRAF-interacting protein (TRIP) negatively regulates IFN-beta production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1. J Exp Med 209:1703–1711. http://dx.doi.org/10.1084/jem.20120024.
   PubMed Web of Science ®Google Scholar
• Gao S, Song L, Li J, Zhang Z, Peng H, Jiang W, Wang Q, Kang T, Chen S, Huang W. 2012. Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. Cell Microbiol 14:1849–1866. http://dx.doi.org/10.1111/cmi.12005.
   PubMed Web of Science ®Google Scholar
• Chen S, Sheng C, Liu D, Yao C, Gao S, Song L, Jiang W, Li J, Huang W. 2013. Enhancer of Zeste homolog 2 is a negative regulator of mitochondria-mediated innate immune responses. J Immunol 191:2614–2623. http://dx.doi.org/10.4049/jimmunol.1203143.
   PubMedGoogle Scholar
• Liu E, Cote JF, Vuori K. 2003. Negative regulation of FAK signaling by SOCS proteins. EMBO J 22:5036–5046. http://dx.doi.org/10.1093/emboj/cdg503.
   PubMedGoogle Scholar
• Lei C-Q, Zhong B, Zhang Y, Zhang J, Wang S, Shu H-B. 2010. Glycogen synthase kinase 3 beta regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity 33:878–889. http://dx.doi.org/10.1016/j.immuni.2010.11.021.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:805–820. http://dx.doi.org/10.1016/j.cell.2010.01.022.
   PubMed Web of Science ®Google Scholar
• Orr SJ, Morgan NM, Buick RJ, Boyd CR, Elliott J, Burrows JF, Jefferies CA, Crocker PR, Johnston JA. 2007. SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses. J Biol Chem 282:3418–3422. http://dx.doi.org/10.1074/jbc.C600216200.
   PubMed Web of Science ®Google Scholar
• Parvatiyar K, Barber GN, Harhaj EW. 2010. TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J Biol Chem 285:14999–15009. http://dx.doi.org/10.1074/jbc.M110.109819.
   PubMed Web of Science ®Google Scholar
• Charoenthongtrakul S, Gao L, Parvatiyar K, Lee D, Harhaj EW. 2013. RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling. PLoS One 8:e53717. http://dx.doi.org/10.1371/journal.pone.0053717.
   PubMedGoogle Scholar
• Ikeda F, Hecker CM, Rozenknop A, Nordmeier RD, Rogov V, Hofmann K, Akira S, Doetsch V, Dikic I. 2007. Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes. EMBO J 26:3451–3462. http://dx.doi.org/10.1038/sj.emboj.7601773.
   PubMed Web of Science ®Google Scholar
• Chen H, Sun H, You F, Sun W, Zhou X, Chen L, Yang J, Wang Y, Tang H, Guan Y, Xia W, Gu J, Ishikawa H, Gutman D, Barber G, Qin Z, Jiang Z. 2011. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147:436–446. http://dx.doi.org/10.1016/j.cell.2011.09.022.
   PubMed Web of Science ®Google Scholar